EGFR and neoplasm: From one standpoint, a higher affinity for EGFR should translate into a greater proportion of mAb-bound EGFR; conversely, however, studies have observed that a KD between 1 and 10 nM is optimal for anti-EGFR mAb tumor targeting, accumulation, and retention (11).